Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-03

Clinical Trial Update: Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether vitamin D supplementation affects reported rates of taxane-induced neuropathy. The study, sponsored by Virginia Common…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Neuropathic Pain | Phase 2 | Status: RECRUITING